BCL6 translocations are observed with a higher frequency in the non-GC DLBCL subtype, although studies on the influence of BCL6 gene rearrangement in patient outcomes have yielded conflicting results [21], [24], [26]–[29]. The gene discussed is BCL6; the disease is diffuse large B-cell lymphoma.